Investment Analysts’ Recent Ratings Updates for Axsome Therapeutics (AXSM)
Axsome Therapeutics (NASDAQ: AXSM) recently received a number of ratings updates from brokerages and research firms: 3/6/2025 – Axsome Therapeutics had its “buy” rating reaffirmed by analysts at HC Wainwright. They now have a $200.00 price target on the stock. 3/3/2025 – Axsome Therapeutics had its price target raised by analysts at Robert W. Baird […]
Axsome Therapeutics (NASDAQ: AXSM) recently received a number of ratings updates from brokerages and research firms: 3/6/2025 – Axsome Therapeutics had its “buy” rating reaffirmed by analysts at HC Wainwright. They now have a $200.00 price target on the stock. 3/3/2025 – Axsome Therapeutics had its price target raised by analysts at Robert W. Baird […]
